Hi-TIDe : T cell discovery

HARARI Lab

Our focus

Our objective is to unveil the dynamic of T-cell specificities and antigen recognition in patients receiving cellular therapies and to develop new knowledge and methods leading to early clinical translation in the domain of T-cell therapy.

TOP ^

Our projects

  • We have designed novel culture methods to generate tumor-infiltrating lymphocyte (TILs) populations that are highly enriched in neoepitope-specific CD8 T cells
  • We have developed sensitive and high-throughput methodologies to interrogate T cells and analyze repertoires of T-cell receptors (TCRs) and have developed unique functional assays to profile tumor antigen-specific T cells
  • We have established a multidisciplinary consortium (FNS Synergia), including bio-engineering and bioinformatics, to interrogate antitumoral immunity and to develop next-generation cellular immunity
  • We have established mass cytometry analyses on tissue and cell suspension to interrogate human samples of patients undergoing T cell therapy
  • We also use single cell sequencing (RNA and TCRs) to profile patients adoptively transferred with autologous TILs to understand the dynamic of individual clonotypes in vitro (during TIL expansion) and in vivo (after infusion to patients)

TOP ^

KEY PUBLICATIONS

UNIL web teasers general.png

TOP ^

Follow us:  

CONTACT

Lausanne Oncology HARARI lab.png

Alexandre HARARI
Group leader
Human integrated tumor immunology discovery engine (Hi-TIDe)

Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne

Ludwig Lausanne RGB-crop461x374.jpg (Print)

Phone +41 79 5567708
E-mail

TOP ^

CONNECT WITH ME

WEB medallions 150 x100-1.png

Featured publication -------

VIGNETTE web (3).png

Efficient identification of neoantigens and cognate TCRs in human solid tumors
Aug 2021 in press M. Arnaud...G. Coukos & A. Harari

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer Research Université de Lausanne Centre Hospitalier Universitaire Vaudois (CHUV)